HomeCompareBAX vs KLAC

BAX vs KLAC: Dividend Comparison 2026

BAX yields 2.28% · KLAC yields 0.55%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KLAC wins by $774.6K in total portfolio value· pulled ahead in Year 2
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
KLAC
KLAC
● Live price
0.55%
Share price
$1,382.58
Annual div
$7.60
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$795.3K
Annual income
$589,306.66
Full KLAC calculator →

Portfolio growth — BAX vs KLAC

📍 KLAC pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXKLAC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + KLAC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
KLAC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
KLAC
Annual income on $10K today (after 15% tax)
$46.72/yr
After 10yr DRIP, annual income (after tax)
$500,910.66/yr
At 15% tax rate, KLAC beats the other by $500,901.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + KLAC for your $10,000?

BAX: 50%KLAC: 50%
100% KLAC50/50100% BAX
Portfolio after 10yr
$407.9K
Annual income
$294,658.46/yr
Blended yield
72.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KLAC right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
KLAC
Analyst Ratings
27
Buy
14
Hold
2
Sell
Consensus: Buy
Price Target
$1,696.31
+22.7% upside vs current
Range: $1,400.00 — $1,900.00
Altman Z
12.3
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
KLAC buys
8
PoliticianChamberTickerTypeAmountDate
Val Hoyle🏢 House$KLAC▼ Sell$1,001 - $15,0002025-09-23
Valerie Hoyle🏢 House$KLAC▲ Buy$1,001 - $15,0002025-07-28
Valerie Hoyle🏢 House$KLAC▼ Sell$1,001 - $15,0002025-04-29
William R. Keating🏢 House$KLAC▲ Buy$1,001 - $15,0002025-01-24
Gilbert Cisneros🏢 House$KLAC▼ Sell$1,001 - $15,0002025-01-13
Valerie Hoyle🏢 House$KLAC▲ Buy$1,001 - $15,0002024-10-29
John James🏢 House$KLAC▼ Sell$1,001 - $15,0002024-09-04
John James🏢 House$KLAC▼ Sell$1,001 - $15,0002024-06-26
Tommy Tuberville🏛 Senate$KLAC▼ Sell$1,001 - $15,0002024-05-03
Ro Khanna🏢 House$KLAC▲ Buy$1,001 - $15,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXKLAC
Forward yield2.28%0.55%
Annual dividend / share$0.36$7.60
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%100%
Portfolio after 10y$20.6K$795.3K
Annual income after 10y$10.26$589,306.66
Total dividends collected$602.00$757.1K
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusHoldBuy
Analyst price target$19.75$1,696.31

Year-by-year: BAX vs KLAC ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrKLAC PortfolioKLAC Income/yrGap
1$10,866$166.33$10,810$109.94+$56.00BAX
2← crossover$11,750$123.31$11,789$222.14$39.00KLAC
3$12,664$90.97$13,067$452.81$403.00KLAC
4$13,617$66.89$14,920$938.13$1.3KKLAC
5$14,619$49.07$17,966$2,002.14$3.3KKLAC
6$15,679$35.94$23,730$4,506.49$8.1KKLAC
7$16,802$26.30$36,517$11,125.83$19.7KKLAC
8$17,998$19.23$71,075$32,001.78$53.1KKLAC
9$19,272$14.05$192,474$116,423.57$173.2KKLAC
10$20,631$10.26$795,254$589,306.66$774.6KKLAC

BAX vs KLAC: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

KLACTechnology

KLA Corporation designs, manufactures, and markets process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide. It operates through four segments: Semiconductor Process Control; Specialty Semiconductor Process; PCB, Display and Component Inspection; and Other. The company offers integrated circuit (IC) manufacturing products that comprises wafer inspection and review, and metrology; wafer and substrate defect inspection and metrology; reticle defect inspection and metrology; chemical/materials quality analysis; in situ process management and wafer handling diagnostics for IC and original equipment manufacturer (OEM) manufacturing; software products to provide run-time process control, defect excursion identification, process corrections, and defect classification; and refurbished and remanufactured products. It also provides specialty semiconductor manufacturing, benchtop metrology, surface characterization, and electrical property measurement services for general purpose/ lab applications; etch, plasma dicing, deposition, and other wafer processing technologies and solutions for the semiconductor and microelectronics industry. In addition, the company offers direct imaging, inspection, optical shaping, additive printing, and computer-aided manufacturing and engineering solutions for the PCB market; inspection and electrical testing systems to identify and classify defects, as well as systems to repair defects for the display market; and inspection and metrology systems for quality control and yield improvement in advanced and traditional semiconductor packaging markets. The company was formerly known as KLA-Tencor Corporation and changed its name to KLA Corporation in July 2019. KLA Corporation was incorporated in 1975 and is headquartered in Milpitas, California.

Full KLAC Calculator →
📬

Get this BAX vs KLAC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.